Trade IBO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Impact BioMedical, Inc. (IBO) is trading at US$0.59, up 3.26% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$51.75M. Over the past 52 weeks, IBO has traded between US$0.37 and US$0.83. On Syfe you can trade IBO with $0 commission and add it to your watchlist.
| Previous close | US$0.57 |
|---|---|
| Market cap | US$51.75M |
| 52-week range | US$0.37 – US$0.83 |
| Volume | 97.26K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Impact BioMedical, Inc.
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.
Year: 2024
Impact BioMedical, Inc. (IBO) stock is trading at US$0.59, +3.26% from the previous close of US$0.57.
The market cap for Impact BioMedical, Inc. (IBO) stock is approximately US$51.75M.
The 52-week high for Impact BioMedical, Inc. (IBO) stock is US$0.83.
The 52-week low for Impact BioMedical, Inc. (IBO) stock is US$0.37.
Impact BioMedical, Inc. (IBO) does not currently pay a dividend.
Stay on top of IBO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
